Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health (FAMU CoPPS, IPH), Pharmaceutical Sciences Professor, Mandip Sachdeva, Ph.D., was recently awarded funding for his grant proposal entitled “Hyaluronic acid-functionalized, Cannabidiol-loaded Mesenchymal Stem Cells (MSC)-Derived Exosomes for Drug-Resistant Cancers” through the Consortium for Medical Marijuana (MMJ) Clinical Outcomes Research Grants Program.
The Consortium for Medical Marijuana Clinical Outcomes Research, which is composed of public and private universities, engaged in research on clinical outcomes of medical marijuana. The consortium will evaluate the safety and effectiveness of medical marijuana, consider dosing and routes of administration, including the study of the effects of smoking medical marijuana versus other methods of consumption.
Funding recommendations were made after thoughtful and careful consideration at the MMJ Clinical Outcomes Consortium Research Board meeting in Fall 2019. Out of 41 proposal submissions by investigators from different consortium member institutions for the 2019 funding cycle, Dr. Sachdeva’s proposal was one of the ten that was chosen. His proposal for $71,250 was approved for the period of December 1, 2019, through July 31, 2020.
“We would like to applaud Dr. Sachdeva for his excellent grantsmanship and significant accomplishment in securing extramural funding,” said Associate Dean of Pharmaceutical Sciences, Selina Darling-Reed, Ph.D. “His continued excellence is an inspiration to us all.”